146 related articles for article (PubMed ID: 11230874)
1. Nicotinic receptor-mediated protection against beta-amyloid neurotoxicity.
Shimohama S; Kihara T
Biol Psychiatry; 2001 Feb; 49(3):233-9. PubMed ID: 11230874
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Shimohama S
Biol Pharm Bull; 2009 Mar; 32(3):332-6. PubMed ID: 19252273
[TBL] [Abstract][Full Text] [Related]
3. alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity.
Kihara T; Shimohama S; Sawada H; Honda K; Nakamizo T; Shibasaki H; Kume T; Akaike A
J Biol Chem; 2001 Apr; 276(17):13541-6. PubMed ID: 11278378
[TBL] [Abstract][Full Text] [Related]
4. Nicotine and its interaction with beta-amyloid protein: a short review.
Zamani MR; Allen YS
Biol Psychiatry; 2001 Feb; 49(3):221-32. PubMed ID: 11230873
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity.
Kihara T; Shimohama S; Sawada H; Kimura J; Kume T; Kochiyama H; Maeda T; Akaike A
Ann Neurol; 1997 Aug; 42(2):159-63. PubMed ID: 9266724
[TBL] [Abstract][Full Text] [Related]
6. α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling.
Yu W; Mechawar N; Krantic S; Quirion R
J Neurochem; 2011 Nov; 119(4):848-58. PubMed ID: 21884524
[TBL] [Abstract][Full Text] [Related]
7. Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity.
Seo J; Kim S; Kim H; Park CH; Jeong S; Lee J; Choi SH; Chang K; Rah J; Koo J; Kim E; Suh Y
Biol Psychiatry; 2001 Feb; 49(3):240-7. PubMed ID: 11230875
[TBL] [Abstract][Full Text] [Related]
8. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
Kawamata J; Shimohama S
J Alzheimers Dis; 2011; 24 Suppl 2():95-109. PubMed ID: 21403387
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.
Kawamata J; Suzuki S; Shimohama S
Ther Adv Chronic Dis; 2011 May; 2(3):197-208. PubMed ID: 23251750
[TBL] [Abstract][Full Text] [Related]
10. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease.
Nagele RG; D'Andrea MR; Anderson WJ; Wang HY
Neuroscience; 2002; 110(2):199-211. PubMed ID: 11958863
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.
Takada-Takatori Y; Kume T; Sugimoto M; Katsuki H; Sugimoto H; Akaike A
Neuropharmacology; 2006 Sep; 51(3):474-86. PubMed ID: 16762377
[TBL] [Abstract][Full Text] [Related]
12. [Amyloid cascade hypothesis of Alzheimer's disease and alpha 7 nicotinic receptor].
Hashimoto K; Iyo M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Apr; 22(2):49-53. PubMed ID: 12050852
[TBL] [Abstract][Full Text] [Related]
13. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.
Kihara T; Shimohama S; Urushitani M; Sawada H; Kimura J; Kume T; Maeda T; Akaike A
Brain Res; 1998 May; 792(2):331-4. PubMed ID: 9593977
[TBL] [Abstract][Full Text] [Related]
15. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
Kihara T; Sawada H; Nakamizo T; Kanki R; Yamashita H; Maelicke A; Shimohama S
Biochem Biophys Res Commun; 2004 Dec; 325(3):976-82. PubMed ID: 15541385
[TBL] [Abstract][Full Text] [Related]
16. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo.
Li XD; Arias E; Jonnala RR; Mruthinti S; Buccafusco JJ
J Mol Neurosci; 2005; 27(3):325-36. PubMed ID: 16280603
[TBL] [Abstract][Full Text] [Related]
17. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S; Maskos U
Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection by nicotine against colchicine-induced apoptosis is mediated by PI3-kinase--Akt pathways.
Huang X; Cheng Z; Su Q; Zhu X; Wang Q; Chen R; Wang X
Int J Neurosci; 2012 Jun; 122(6):324-32. PubMed ID: 22248034
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
